Xiao Shi

Title: Innovations by Inventor Xiao Shi

Introduction

Xiao Shi is a notable inventor based in Cupertino, CA (US). She has made significant contributions to the field of virology, particularly in the development of non-tumorigenic cell lines for vaccine production. With a total of 3 patents, her work is paving the way for advancements in vaccine technology.

Latest Patents

One of her latest patents is focused on a non-tumorigenic MDCK cell line for propagating viruses. This invention provides novel MDCK-derived adherent non-tumorigenic cell lines that can be grown in the presence or absence of serum. The cell lines are particularly useful for the production of vaccine material, including influenza viruses. The invention also includes methods and media formulations for the adaptation and cultivation of MDCK cells, ensuring they remain non-tumorigenic. Additionally, it outlines methods for producing vaccine material, such as influenza virus, in these innovative cell lines.

Career Highlights

Xiao Shi is currently associated with Medimmune Limited, where she continues to contribute to groundbreaking research in virology. Her expertise and innovative approach have positioned her as a key player in her field.

Collaborations

Throughout her career, Xiao has collaborated with notable colleagues, including Richard Schwartz and John Michael Berry. These partnerships have further enhanced her research and development efforts.

Conclusion

Xiao Shi's contributions to the field of virology through her innovative patents and collaborations highlight her importance as an inventor. Her work is instrumental in advancing vaccine production technologies, which can have a significant impact on public health.